Form D — GevRx Nutraceuticals, Inc.
0001213900-26-101304 · filed Sep 18, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $3,000,000
- Reported amount sold
- $300,000
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- GevRx Nutraceuticals, Inc.
- CIK
- 2156105
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 20 MARBLE LOOP
STATEN ISLAND, NY 10309 - Phone
- (917) 939-9424
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James Thomas Christopher · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Douglas Spiel, M.D. · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Mary Stephen Esposito · DirectorStaten Island, NY Find on LinkedIn ↗
-
Dylan Tyler Spiel · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Michael J. Betley, Ph.D. · Executive OfficerStaten Island, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗